Company Profiles

driven by the PitchBook Platform

TearScience

Description

Developer of medical devices designed to provide treatment for dry eye. The company's medical devices involve in identifying, diagnosing and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye, with an FDA-cleared liquid that restores gland function, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

2005

Founded

PRIVATE

Status

51-200

Employees

Series D

Latest Deal Type

$19.2M

Latest Deal Amount

$166M

Total Amount Raised

Description

Developer of medical devices designed to provide treatment for dry eye. The company's medical devices involve in identifying, diagnosing and treating Meibomian Gland Dysfunction (MGD), the leading cause of dry eye, with an FDA-cleared liquid that restores gland function, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Website:

www.tearscience.com

Formerly Known As

Kolis Scientific

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Diagnostic Equipment
Discovery Tools (Healthcare)

Primary Office

5151 McCrimmon Parkway Suite 250 Morrisville, NC 27560United States +1 (919) 459-4880
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore TearScience's full profile, request a free trial.

TearScience Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

TearScience Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

TearScience Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
De Novo VenturesVenture CapitalMinority000 0000000 0000
EW Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
General Catalyst PartnersVenture CapitalMinority000 0000000 0000
HealthCare Royalty PartnersPE/BuyoutMinority000 0000000 0000
Patricia IndustriesPE/BuyoutMinority000 0000000 0000
De Novo Ventures Venture Capital
EW Healthcare Partners Growth/Expansion
General Catalyst Partners Venture Capital
HealthCare Royalty Partners PE/Buyout
Patricia Industries PE/Buyout

TearScience Executive Team (14)

NameTitleBoard
Seat
Contact
Info
Joseph BooradyPresident & Chief Executive Officer
Manoj GeorgeChief Financial Officer
Donald Korb MDChief Technical Officer & Co-Founder
Randy FriedArea Director
Samuel KimDirector, Clinical Training
Joseph Boorady President & Chief Executive Officer
Manoj George Chief Financial Officer
Donald Korb MD Chief Technical Officer & Co-Founder
Randy Fried Area Director
Samuel Kim Director, Clinical Training

TearScience Board Members (1)

NameRepresentingRoleSinceContact
Info
Abhijeet LelePatricia IndustriesManaging Director & Head of Healthcare Investing000 0000
Abhijeet Lele Managing Director & Head of Healthcare Investing Patricia Industries
Request full access to PitchBook